Phibro Animal Health Corporation (PAHC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Phibro Animal Health Corporation (PAHC:NASDAQ), powered by AI.

Current Price
$31.87
P/E Ratio
26.7
Market Cap
1.3B
Sector
Healthcare
What is the Phibro Animal Health Corporation stock price forecast?

Phibro Animal Health Corporation is currently trading at $31.87. View real-time AI analysis on Alpha Lenz.

What is Phibro Animal Health Corporation insider trading activity?

View the latest insider trading data for Phibro Animal Health Corporation on Alpha Lenz.

What is Phibro Animal Health Corporation's P/E ratio?

Phibro Animal Health Corporation's P/E ratio is 26.7.

Phibro Animal Health Corporation

NASDAQ · PAHC
$31.87-0.41(-1.27%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Phibro Animal Health Corporation's future dividend policy...
Alpha Chat Insight

Phibro Animal Health Corporation trades at a P/E of 26.7 (premium valuation) with strong ROE of 17.8%. 3Y revenue CAGR of 11.2% highlights clear growth momentum.

Ask for details

Company Overview

Phibro Animal Health Corporation is a pharmaceutical company that focuses on the development, manufacturing, and marketing of a wide range of animal health and mineral nutrition solutions. Primarily, the company serves the livestock and poultry sectors by providing medications and vaccines that enhance the health and productivity of animals. Phibro's extensive product portfolio includes antimicrobials, vaccines, mineral premixes, and specialty products developed to support the animal agriculture industry. The company plays a significant role in improving animal welfare as well as animal-derived food safety, thus contributing directly to the agricultural supply chain. Established in 1946 and headquartered in Teaneck, New Jersey, Phibro operates globally, catering to the needs of veterinarians, farmers, and feed producers across diverse markets. Its products are pivotal in addressing challenges such as outbreaks of diseases among livestock, thereby helping to ensure the profitability and sustainability of animal farming operations worldwide.

CEOMr. Jack Clifford Bendheim
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,475

Company Statistics

FY 2025

Profile

$1.29BMarket Cap
$1.30BRevenue
0.00Shares Out
2,475Employees

Margins

30.85%Gross
11.94%EBITDA
8.52%Operating
5.25%Pre-Tax
3.72%Net

Valuation

26.74P/E
4.52P/B
1.00EV/Sales
12.82EV/EBITDA
30.86P/FCF

Growth (CAGR)

11.22%Rev 3Yr
10.12%Rev 5Yr
11.83%Op Inc 3Yr
9.81%Op Inc 5Yr
-0.62%Net Inc 3Yr
7.54%Net Inc 5Yr

Returns

4.12%ROA
17.80%ROE
8.64%ROIC

Financial Health

$68.04MCash & Cash Equivalents
$1.01BNet Debt
376.37%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Phibro Animal Health Corporation (ticker: PAHC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,475 employees. Market cap is $1.3B.

The current price is $31.87 with a P/E ratio of 26.74x and P/B of 4.52x.

ROE is 17.80% and operating margin is 8.52%. Annual revenue is $1.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Phibro Animal Health Corporation (PAHC) Stock Forecast 2026 $31.87 — Price, Financials & Analyst Targets | Alpha Lenz